Brain is not blood

Dipeptidyl peptidase IV is best known as a hot target for diabetes. But Probiodrug AG, whose founders have been studying DPP IV for nearly three decades, thinks its inhibitors will find use in CNS disorders as well. Morphochem AG agrees, and the two

Read the full 432 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE